Human Health

Boehringer Ingelheim is a research-driven group of companies dedicated to the discovery, development, manufacture and marketing of innovative health care products.

Human Health

Further  Topics

Heart Diseases

Cardiovascular disease, including heart disease and stroke, is a major global health concern and the leading cause of death and disability worldwide.
Heart Diseases

Metabolic Diseases

About 425 million adult people in the world are living with diabetes, with Type 2 diabetes accounting for 90 – 95% of all cases. This number is projected to increase to 629 million people by 2045.
Metabolic Diseases

Cancer

We have a clear aspiration – to transform the lives of people with cancer by delivering meaningful advances, with the ultimate goal of curing a range of cancers
Cancer

Lung Diseases

Boehringer Ingelheim has 100 years of heritage in respiratory disease. Since 1921 we have emerged as a leader in this disease area.
Lung Diseases

Skin Diseases

Living with inflammatory and fibrotic diseases greatly impacts patients’ lives, both physically and emotionally. These patients guide and inspire us to turn innovative science into life-changing medical breakthroughs.
Skin Diseases

Mental Health

Everyone’s experience with schizophrenia is unique. Discover the real stories of how schizophrenia impacts all aspects of life.

Retinal Diseases

At Boehringer Ingelheim, we have expanded our global research and development activities to tackle eye diseases. Visual impairment and blindness have a profound and devastating impact on the lives of the affected person.
Retinal Diseases

Our Responsibility

The lives of animals and humans are interconnected in deep and complex ways. We know that when animals are healthy, humans are healthier, too. By delivering value through innovation, we enhance the well-being of both.
Our Responsibility

NP-GB-104849    August 2024